Becton, Dickinson and Company (bdx)
BDX News
Live headlines and press releases for Becton, Dickinson and Company load in the terminal.
Company news & press releases is available in Vest Terminal for Professional and Enterprise subscribers.
Becton, Dickinson and Company FAQ
What does Becton, Dickinson and Company (BDX) do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worl…
What is BDX's P/E ratio?
Becton, Dickinson and Company has a trailing P/E of 29.76× based on publicly available market data.
Does BDX pay a dividend?
Indicated dividend yield: 2.5%. Confirm ex-dates and payout history in Vest Terminal.
What sector is BDX in?
Becton, Dickinson and Company is classified in Healthcare (Medical Instruments & Supplies) on NYQ.
What is BDX's market capitalization?
Approximate market cap: $48.79B.
What are the main risks for BDX?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of BDX?
Potential positives include revenue growth of 5.2% year-over-year, gross margin of 47.1% supports competitive unit economics.
Where can I get analyst estimates for BDX?
Consensus estimates, price targets, and detailed analyst data for Becton, Dickinson and Company are available to Professional subscribers in Vest Terminal — not on this public summary page.